Angry investors say sale grossly undervalues Ocata – The Boston Globe
|
Angry investors say sale grossly undervalues Ocata
The Boston Globe At issue is not only the sale price for Ocata, which has about 35 employees, but also its intellectual property in embryonic stem cells. Such cells can grow others that Ocata initially hopes to implant in the eyes of patients suffering from macular … |
